Reposted by Clever Dame
CDC is reviving a study that withholds the hepatitis B birth dose from newborns in Guinea-Bissau.
WHO raised serious ethical concerns. And $1.6M is being pulled from global health security to pay for it.
Public outcry helped halt it once. We can do it again.
www.rollingstone.com/politics/pol...
rollingstone.com
CDC Is Moving Forward With a Previously Shelved Controversial Hepatitis B Vaccine Study
“It’s a wholly unethical trial, and it shouldn’t be allowed,” says Dr. Paul Offit of Guinea-Bissau study